BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  FDA

  Takeda Racks Up Designations for Rare Lung Cancer Drug

  The FDA awarded a number of designations for Takeda’s candidate drug EXKIVITY in the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer.

  September 16, 2021

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  Deals

  Medtech Start-Up Becomes Nasdaq’s First Hong Kong Unicorn

  Hong Kong-based Prenetics Group Limited, a medical diagnostic startup, is making its debut on the Nasdaq through a merger with Artisan Acquisitions Corp. The deal is valued at $1.25 billion.

  September 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Approves First Human Trial for Potential CRISPR-Led HIV Cure

  The FDA’s IND approval sets the stage for the very first Phase I/II trial to evaluate EBT-101 as a functional cure for chronic HIV based on the endpoints of safety, tolerability, and efficacy.

  September 16, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Alpine, Anjarium and Amolyt Net New Funds on Lucrative Investment Day

  The proceeds will be used for the companies’ growth, to help develop their platforms and advance their pipelines.

  September 16, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Intellia Therapeutics Set to Enter Clinic with First Solo Ex Vivo Candidate

  NTLA-5001 is being developed for the treatment of acute myeloid leukemia (AML).

  September 16, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Diseases Gets More Support

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  September 16, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  Elizabeth Holmes Trial: Whistleblower Testifies to “Frequent” Data Manipulation

  Erika Cheung testified that the data manipulation happened “frequently,” in order to make the company’s lead asset look good to investors.

  September 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  COVID-19 Cements Science Journalism’s Place as a Top News Priority

  The COVID-19 pandemic has changed science journalism. Semantics aside, though, science and health care have taken a new position in the hierarchy of top news priorities.

  September 16, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Seven Companies Present Exciting News at ESMO 2021

  Biopharma companies big and small are presenting exciting clinical studies at the European Society for Medical Oncology Congress 2021.

  September 16, 2021

   · 

  6 min read

   · 

  Mark Terry
• 

  FDA

  COVID-19 Update: Vaccines for Kids and an Upcoming Verdict on Boosters

  FDA external advisors will meet to consider Pfizer and BioNTech data in support of booster shots. The two companies also expect to file for Vaccine Authorization for children in the coming months.

  September 16, 2021

   · 

  3 min read

   · 

  Mark Terry